april 2026

Testing New Therapies for Ovarian Cancer in a 3D Model

A new 3D peritoneal matrix model recreates the tumour microenvironment of metastatic ovarian cancer, enabling more physiologically relevant studies and the preclinical evaluation of both conventional and cell-based therapies.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Få adgang
Hvis du allerede har en profil: Log ind

Forfatter

Christiane Helgestad Gjerde

MD, PhD, Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway

Forfatter

Line Bjørge

MD, PhD, MBA, medical director, gynecological oncology, Haukeland University Hospital, professor, obstetrics and gynecology, Department of Clinical Science, co-director, Centre for Cancer Biomarkers CCBIO, University of Bergen, Norway

Forfatter

Emmet McCormack

PhD, head, Pharmaceutics, professor, pharmacy, PI, Centre for Cancer Biomarkers CCBIO, associated PI, K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, senior researcher, Department of Medicine, Hematology Section, Haukeland University Hospital associated PI, Centre for Cancer Cell Reprogramming (CanCell), University of Oslo, Norway

Forfatter

Katrin Kleinmanns

PhD, M.Sc., postdoctoral researcher, Department of obstetrics and Gynecology, Haukeland University Hospital, Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, Norway

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen

Testing New Therapies for Ovarian Cancer in a 3D Model

Få adgang

Relateret indhold

Brænder du for at skrive?